364 related articles for article (PubMed ID: 28219190)
1. [Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment of sepsis patients].
Xu XL; Yan FD; Yu JQ; Chen QH; Lin H; Zheng RQ
Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):343-346. PubMed ID: 28219190
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of dynamic monitoring of procalcitonin in guiding the use of antibiotics in patients with sepsis in ICU].
Liu BH; Li HF; Lei Y; Zhao SX; Sun ML
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):690-3. PubMed ID: 24225216
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
6. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
[TBL] [Abstract][Full Text] [Related]
7. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
[TBL] [Abstract][Full Text] [Related]
9. Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit.
Bishop BM; Bon JJ; Trienski TL; Pasquale TR; Martin BR; File TM
Ann Pharmacother; 2014 May; 48(5):577-83. PubMed ID: 24519479
[TBL] [Abstract][Full Text] [Related]
10. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.
Prkno A; Wacker C; Brunkhorst FM; Schlattmann P
Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
[TBL] [Abstract][Full Text] [Related]
14. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of serum procalcitonin for infection in the immunocompromised critically ill patients with suspected infection].
Yu X; Ma X; Ai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):477-83. PubMed ID: 26049187
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
[TBL] [Abstract][Full Text] [Related]
18. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
[TBL] [Abstract][Full Text] [Related]
20. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].
Ma J; Wang S; Chen D; Duan J; Li C; Li G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]